Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A first-in-human phase 1a study of LP-184, a tumor-site activated novel alkylating agent, in patients with advanced solid tumors.

Investigational new drugs·2026
Same author

Sphingosine kinase 1 is dysregulated via hypoxia-inducible factor 1α in oral squamous cell carcinoma.

The Indian journal of medical research·2026
Same author

Transcranial acoustoelectric imaging (tABI) of seizure activity in human head model with neuronavigation.

Journal of neural engineering·2026
Same author

Challenging conventional wisdom: A fresh look at the litter effect in rats.

The Journal of physiology·2026
Same author

A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma.

Liver cancer·2026
Same author

Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 Cases.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Related Experiment Video

Updated: Jun 28, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K

Gene Expression Patterns Associated with Survival in Glioblastoma.

Christopher Morrison1, Eric Weterings1, Nicholas Gravbrot2

  • 1Department of Radiation Oncology, University of Arizona, Tucson, AZ 85719, USA.

International Journal of Molecular Sciences
|April 13, 2024
PubMed
Summary

A new Glioblastoma Prognostic Index (GPI) using four genes (COL1A2, IGFBP3, NGFR, WIF1) accurately predicts patient survival. High GPI scores indicate shorter survival, aiding glioblastoma prognosis and clinical trial stratification.

Keywords:
MGMTTCGAdifferential gene expressionglioblastomaglioblastoma prognostic index

More Related Videos

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.6K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

7.9K

Related Experiment Videos

Last Updated: Jun 28, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.6K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

7.9K

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis.
  • Accurate prognostic markers are crucial for personalized treatment strategies in GBM patients.

Purpose of the Study:

  • To identify gene expression alterations associated with overall survival (OS) in glioblastoma.
  • To develop and validate a novel mRNA-based prognostic index for GBM.

Main Methods:

  • Gene expression profiling using the Nanostring nCounter platform.
  • Identification of four significant genes (COL1A2, IGFBP3, NGFR, WIF1) differentiating GBM from normal brain tissue.
  • Development of a Glioblastoma Prognostic Index (GPI) using a multivariate Cox model including age, extent of resection, and MGMT promoter methylation.

Main Results:

  • The GPI score showed an inverse correlation with patient survival in both discovery and validation cohorts (TCGA).
  • High GPI scores were associated with significantly shorter median OS (7.5 months discovery, 10.5 months validation).
  • Low GPI scores were associated with significantly longer median OS (20.1 months discovery, 16.9 months validation).

Conclusions:

  • The novel mRNA-based GPI is a valuable tool for classifying GBM patients into distinct risk groups.
  • The GPI can refine prognosis estimates, potentially improving treatment decisions and clinical trial stratification for glioblastoma.